Jennifer L Harris

Altered Substrate Specificity of Drug-Resistant Human Immunodeficiency Virus Type 1 Protease

Sami Mahrus, Neil Parkin, Dustin J Maly, 2002, Journal of Virology.

Crystal structure of the ALK (anaplastic lymphoma kinase) catalytic domain.

Glen Spraggon, Scott A Lesley, Nanxin Li, 2010, The Biochemical journal.

The ALK inhibitor ceritinib overcomes crizotinib resistance in non-small cell lung cancer.

Makoto Nishio, Peter McNamara, Ryohei Katayama, 2014, Cancer discovery.

Synthesis and evaluation of arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 3: heterocyclic P3.

Jun Li, Glen Spraggon, Tove Tuntland, 2006, Bioorganic & medicinal chemistry letters.

Identification of synthetic lethality of PRKDC in MYC-dependent human cancers by pooled shRNA screening

Jun Liu, S. Batalov, A. Orth, 2014, BMC Cancer.

From Split-Pool Libraries to Spatially Addressable Microarrays and Its Application to Functional Proteomic Profiling.

Peter G Schultz, Nicolas Winssinger, P. Schultz, 2001, Angewandte Chemie.

Synthesis and SAR of arylaminoethyl amides as noncovalent inhibitors of cathepsin S: P3 cyclic ethers.

Jun Li, Glen Spraggon, Tove Tuntland, 2006, Bioorganic & medicinal chemistry letters.

Arylaminoethyl carbamates as a novel series of potent and selective cathepsin S inhibitors.

Jun Li, Tove Tuntland, Jennifer L. Harris, 2006, Bioorganic & medicinal chemistry letters.